Skip to content
OpenCapital
Get started

Intellia Therapeutics NTLA Interest Income

Interest Income at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$25.48M+3.3%
ALN
Alnylam PharmaceuticalsALNY
$26.6M-7.2%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.33M-58.6%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$7.87M+4.4%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$4.24M+47.6%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$5.35M-31.5%

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.13B+106%
Enterprise value$2.08B+100%
P/S32.2×+9.5×

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's interest income?
Intellia Therapeutics (NTLA) reported interest income of $5.21M in Q1 2026.
How has Intellia Therapeutics's interest income changed year-over-year?
Intellia Therapeutics's interest income decreased by 39.5% year-over-year, from $8.6M to $5.21M.
What is the long-term trend for Intellia Therapeutics's interest income?
Over 4 years (2021 to 2025), Intellia Therapeutics's interest income has grown at a 118.4% compound annual growth rate (CAGR), from $1.28M to $29.2M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.